Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2020

May 05, 2020

SELL
$16.59 - $34.94 $161,420 - $339,966
-9,730 Closed
0 $0
Q4 2019

Jan 30, 2020

SELL
$22.24 - $27.56 $112,534 - $139,453
-5,060 Reduced 34.21%
9,730 $244,000
Q3 2019

Nov 01, 2019

SELL
$25.56 - $36.1 $6,722 - $9,494
-263 Reduced 1.75%
14,790 $403,000
Q2 2019

Jul 26, 2019

BUY
$24.79 - $32.96 $139,443 - $185,400
5,625 Added 59.66%
15,053 $496,000
Q1 2019

Apr 24, 2019

BUY
$23.31 - $31.41 $219,766 - $296,133
9,428 New
9,428 $296,000
Q4 2018

Feb 01, 2019

SELL
$21.6 - $37.49 $437,400 - $759,172
-20,250 Closed
0 $0
Q3 2018

Oct 25, 2018

BUY
$25.67 - $42.36 $160,052 - $264,114
6,235 Added 44.49%
20,250 $796,000
Q2 2018

Jul 20, 2018

BUY
$17.91 - $26.86 $98,236 - $147,327
5,485 Added 64.3%
14,015 $376,000
Q1 2018

Apr 18, 2018

BUY
$21.37 - $26.6 $182,286 - $226,898
8,530 New
8,530 $227,000

Others Institutions Holding PETQ

About PetIQ, Inc.


  • Ticker PETQ
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 29,312,800
  • Market Cap $908M
  • Description
  • PetIQ, Inc. operates as a pet medication and wellness company in the United States and internationally. It operates in two segments, Products and Services. The company offers Rx pet medications, which include flea and tick control, heartworm preventatives, arthritis, thyroid, diabetes and pain treatments, antibiotics, and other specialty medicat...
More about PETQ
Track This Portfolio

Track Creative Planning Portfolio

Follow Creative Planning and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Creative Planning, based on Form 13F filings with the SEC.

News

Stay updated on Creative Planning with notifications on news.